CLINICAL_TRIALS
trial_result
· 2026-01-02
Clinical Trial Update: Genentech Xenon MRI Idiopathic Pulmonary Fibrosis [Phase 2]
Summary
Phase 2 trial of Xenon MRI for idiopathic pulmonary fibrosis has posted results; the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-02